Clinical Trial Update: Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating different initial oral doses of propranolol for treating ulcerated infantile hemangioma. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Hemangioma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: West China Hospital | Conditions: Infantile Hemangioma | Phase 2, Phase 3 | Status: RECRUITING